Display Settings:

Format

Send to:

Choose Destination

    Biochem Biophys Res Commun. 1992 Nov 16;188(3):1146-52.

    An antibody against a CFTR-derived synthetic peptide, incorporated into living submandibular cells, inhibits beta-adrenergic stimulation of mucin secretion.

    Mills CL, Pereira MM, Dormer RL, McPherson MA.

    Department of Medical Biochemistry, University of Wales College of Medicine, Heath Park, Cardiff, U.K.

    An antibody raised against a peptide in the first nucleotide-binding domain (NBD) of CFTR [1], incorporated into intact rat submandibular acini by hypotonic swelling, inhibited beta-adrenergic stimulated mucin secretion, without affecting cyclic AMP rise. The data are the first to show that a CFTR-antibody-containing cell results in defective stimulation of mucin secretion, as is seen in CF cells, and that this can be reversed by an excessive increase in cyclic AMP.

    PMID: 1280131 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read

    Patient drug information

    • Theophylline (Bronkodyl®, Elixophyllin®, Slo-bid®, ...)

      Theophylline is used to prevent and treat wheezing, shortness of breath, and difficulty breathing caused by asthma, chronic bronchitis, emphysema, and other lung diseases. It relaxes and opens air passages in the lungs, ...